Central obesity but not generalised obesity (body mass index) predicts high prevalence of fatty liver (NAFLD), in recently detected untreated, IGT and type 2 diabetes Indian subjects

Journal of the Indian Medical Association

Volumn 107, Issue 11, 2009, Pages 755-758

  Sanyal, Debmalya ^a,b   Mukhopadhyay, Pradip ^a   Pandit, Kaushik ^a   Mukhopadhyay, Satinath ^a   Chowdhury, Subhankar ^a  

^a INSTITUTE OF POST GRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

^b MEDICAL COLLEGE AND HOSPITAL   (India)

Author keywords

Anthropometric measures; BMI; Central obesity; Fatty liver; NAFLD; Obesity

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY HEIGHT; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETIC PATIENT; FATTY LIVER; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INDIAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREVALENCE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WAIST HIP RATIO; ABDOMINAL FAT; ABDOMINAL OBESITY; CASE CONTROL STUDY; GLUCOSE INTOLERANCE; INDIA; MIDDLE AGED;

ABDOMINAL FAT; ADULT; AGED; BODY MASS INDEX; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FATTY LIVER; GLUCOSE INTOLERANCE; HUMANS; INDIA; MIDDLE AGED; OBESITY, ABDOMINAL; PREVALENCE;

EID: 77954925977     PISSN: 00195847     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Angulo P - Nonalcoholic fatty liver disease. N Engl J Med 2002; 346: 1221-31.
2. Li Z, Clark J, Diehl AM - The liver in obesity and type 2 diabetes mellitus. Clin Liver Dis 2002; 6: 867-77.
3. Knobler H, Schattner A, Zhornicki T, Malnick SD, Keter D, Sokolovskaya N, et al - Fatty liver - an additional and treatable feature of the insulin resistance syndrome. Q J Med 1999; 92: 73-9.
4. Kumar KS, Malet PF - Nonalcoholic steatohepatitis. Mayo Clin Proc 2000; 75: 733-9.
5. Ryysy L, Hakkinen AM, Goto T, Vehkavaara S, Westerbacka J, Halavaara J, et al - Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients. Diabetes 2000; 49: 749-58.
6. Seppala-Lindroos A, Vehkavaara S, Hakkinen AM, Goto T, Westerbacka J, Sovijärvi A, et al - Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum fatty acids independent of obesity in normal men. J Clin Endocrinol Metab 2002; 87: 3023-8.
7. Mishra P, Younossi ZM - Abdominal ultrasound for diagnosis of nonalcoholic fatty liver disease (NAFLD). Am J Gastroenterol 2007; 102: 2716-7.
8. Levy JC, Matthews DR, Hermans MP - Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 1998; 21: 2191-2.
9. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, et al - Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000; 85: 2402-10.
10. Ground KE - Liver pathology in aircrew. Aviat Space Environ Med 1982; 53: 14-8.
11. Hilden M, Christoffersen P, Juhl E, Dalgaard JB - Liver histology in a "normal" population - examinations of 503 consecutive fatal traffic casualties. Scand J Gastroenterol 1977; 12: 593-7.
12. Singh SP, Nayak S, Swain M, Rout N, Mallik RN, Agrawal O, et al - Prevalence of nonalcoholic fatty liver disease in coastal eastern India: a preliminary ultrasonographic survey. Trop Gastroenterol 2004; 25: 76-9.
13. Kelley DE, McKolanis TM, Hegazi RA, Kuller LH, Kalhan SC - Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance. Am J Physiol Endocrinol Metab 2003; 285: E906-E16.
14. Angelico F, Del Ben M, Conti R, Francioso S, Feole K, Fiorello S, et al - Insulin resistance, the metabolic syndrome, and nonalcoholic fatty liver disease. J Clin Endocrinol Metab 2005; 90: 1578-82.
15. Jimba S, Nakagami T, Takahashi M, Wakamatsu T, Hirota Y, Iwamoto Y, et al - Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults. Diabet Med 2005; 22: 1141-5.
16. Gupte P, Amarapurkar D, Agal S, Baijal R, Kulshrestha P, Pramanik S, et al - Non-alcoholic steatohepatitis in type 2 diabetes mellitus. J Gastroenterol Hepatol 2004; 19: 854-8.
17. Akbar DH, Kawther AH - Nonalcoholic fatty liver disease in Saudi type 2 diabetic subjects attending a medical outpatient clinic: prevalence and general characteristics. Diabetes Care 2003; 26: 3351-2.
18. Fan JG, Zhu J, Li XJ, Chen L, Li L, Dai F, et al - Fatty liver and the metabolic syndrome in a general population of Shanghai, China. J Hepatol 2005; 43: 508-14.
19. Raji A, Selly EW, Arky RA, Simonson DC - Body fat distribution and insulin resistance in healthy Asian Indians and Caucasians. J Clin Endocrinol Metab 2001; 86: 5366-71.
20. Sanyal AJ - AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 2002; 123: 1705-25.
21. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ - Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999; 116: 1413-9.
22. TeIi MR, James OF, Burt AD, Bennett MK, Day CP - The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology 1995; 22: 1714-9.
23. Schneider HJ, Glaesmer H, Klotsche J, Böhler S, Lehnert H, Zeiher AM, et al - Accuracy of anthropometric indicators of obesity to predict cardiovascular risk: DETECT Study Group. J Clin Endocrinol Metab 2007; 92: 589-94.
24. Chitturi S, Abeygunasekera S, Farrell GC, Holmes-Walker J, Hui JM, Fung C, et al - NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 2002; 35: 497-9.
25. Madan K, Batra Y, Gupta SD, Chander B, Rajan KD, Tewatia MS, et al - Non-alcoholic fatty liver disease may not be a severe disease at presentation among Asian Indians. World J Gastroenterol 2006; 12: 3400-5.
26. Duseja A, Das A, Dhiman RK, Chawla YK, Das R, Bhadada S, et al - Indian patients with nonalcoholic fatty liver disease presenting with raised transaminases are different at presentation. World J Gastroenterol 2007; 13: 649-50.